TribLIVE

| News


Newsmaker: Dr. Herbert Zeh III

About Adam Smeltz
Adam Smeltz 412-380-5676
Staff Reporter
Pittsburgh Tribune-Review



Contact Us | Video | RSS | Mobile
The Alliance for Cancer Gene Therapy has named Dr. Herbert Zeh III, a UPMC surgical oncologist, its 2012 ACGT Investigator. Zeh is receiving a $500,000 grant with the award. That will help him continue his research into gene therapy for pancreatic cancer. His team is looking into how a modified virus can produce hormones that help combat cancer and cancer recurrence.


By Adam Smeltz

Published: Thursday, October 18, 2012, 12:01 a.m.
Updated: Thursday, October 18, 2012

Noteworthy: The Alliance for Cancer Gene Therapy has named Zeh, a surgical oncologist at UPMC, its 2012 ACGT Investigator. A two-year, $500,000 grant from the alliance will support his gene-therapy research to combat pancreatic cancer.

Residence: Hampton

Age: 45

Family: Wife, Kelly; son, Ryan, 20; daughters, Makenzie, 15, and Teegan, 13

Occupation: Chief, Division of Gastrointestinal Surgical Oncology at UPMC CancerCenter; co-director, UPMC Pancreatic Cancer Center and the University of Pittsburgh Cancer Institute GI Oncology Program

Background: For six years, Zeh has co-directed the Pancreatic Cancer Center, one of the largest pancreatic cancer treatment facilities in the United States.

Education: Bachelor's degree in biology and philosophy, 1989, University of Notre Dame; doctorate in medicine, 1994, University of Pittsburgh

Quote: “Unfortunately, still in 2012, most patients who develop this disease will succumb to it. ... It's the highest mountain out there.”

— Adam Smeltz

Most Popular News

You must be signed in to add comments

To comment, click the Sign in or sign up at the very top of this page.

There are currently no comments for this story.
Subscribe today! Click here for our subscription offers.